Navigation Links
Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
Date:12/11/2012

ative small-molecule drugs for the treatment of cancer and immune mediated diseases. Our mission and goal is to build a viable biopharmaceutical company that designs, develops and commercializes novel therapies intended to improve quality of life, increase duration of life and resolve serious unmet medial healthcare needs; and to identify promising product candidates based on scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner and pursue commercialization and/or development partners when and where appropriate.

Presently, Pharmacyclics has three product candidates in clinical development and several preclinical molecules in lead optimization. We are committed to high standards of ethics, scientific rigor, and operational efficiency as we move each of these programs to viable commercialization.

The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCYC. To learn more about how Pharmacyclics advances science to improve human healthcare visit us at http://www.pharmacyclics.com.

NOTE: This announcement may contain forward-looking statements made in reliance upon the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements, among others, relating to our future capital requirements and the sufficiency of our current assets to meet these requirements, our future results of operations, our expectations for and timing of ongoing or future clinical trials and regulatory approvals for any of our product candidates, and our plans, objectives, expectations and intentions. Because these statements apply to future events, they are subject to risks and uncertainties. When used in this announcement, the words "anticipate", "believe", "estimate", "expect", "expectation", "should", "would", "project", "plan", "p
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
6. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
7. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
8. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
9. Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
10. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... WASHINGTON , May 23, 2013  Vanda Pharmaceuticals Inc. ... company has been named the 2013 Life Science Firm of ... (TCM).  Vanda was honored at the TCM,s 25 ... Bethesda , Maryland.  The Tech Awards Celebration recognizes the ... in Maryland and the surrounding regions. ...
(Date:5/23/2013)... 23, 2013  Haemonetics Corporation (NYSE: HAE ) ... & EVP-Business Development, will present at The Deutsche Bank 38 ... Boston, MA on May 29, 2013 at 1:30pm ... The public may access Mr. Lindop,s presentation live ... Haemonetics Haemonetics (NYSE: HAE ) is ...
(Date:5/23/2013)... , May 23, 2013  A recently published clinical ... Houston, Texas , demonstrates that 3D mammography ... cancer detection. The study, "Implementation of ... Study," was led by Stephen L. Rose ... of the American Journal of Roentgenology (AJR). ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... Taiho Pharmaceutical Co., Ltd. announced on May 31 ... the novel combination antimetabolite TAS-102 will start in June ... double-blind, placebo-controlled Phase III trial that compares TAS-102 with ... safety of TAS-102 when administered to patients with advanced ...
...  Today, at the 52nd annual New Clinical Drug Evaluation ... of Psychiatry at the University of California, Los Angeles ... presented the results from the first 6-subject cohort of ... effects of external trigeminal nerve stimulation (eTNS™) on Post-Traumatic ...
Cached Medicine Technology:Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102 2Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102 3Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 2Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 3Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 4Interim Results Reported for Phase I Open-Label Clinical Trial for the Treatment of PTSD and MDD Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™ 5
(Date:5/24/2013)... New York, New York (PRWEB) May 24, 2013 ... 101 Mobility® is a leading nationwide ... accessibility solutions for both consumer and commercial applications. ... ramps, vertical platform lifts, vehicle lifts for mobility ... elevators, among others. 101 Mobility operates over 30 ...
(Date:5/24/2013)... May 2013, Paris, France: Routinely measuring fractional flow ... angiography for diagnosis of chest pain leads to ... four patients, according to results from a study ... routine pressure wire assessment influence management strategy at ... was designed to assess whether routine assessment of ...
(Date:5/24/2013)... Beach Gardens, FL (PRWEB) May 24, 2013 ... surgeons jealous, Dr. Greg DeLange of the Estetica ... of the hosts of KOOL 105.5 FM’s popular morning show, ... the air about their experiences and their satisfaction with the ... Institute, a cutting-edge facility located in Palm Beach Gardens, very ...
(Date:5/24/2013)... 24, 2013 Electric™ Energy Straws, an exciting ... Rookie Carlos Munoz and will be the lead sponsor on ... the Indianapolis Motor Speedway. Munoz, who is part of Andretti ... 228.342 mph in race, qualifying to be named the 2013 ... row in Sunday’s race. , While Munoz is grabbing ...
(Date:5/24/2013)... 24, 2013 General Data Company ... identification, tracking and data management products and solutions, ... Sciences Inc., (TBS) of Durham, North Carolina, a ... consumables for the clinical and research pathology marketplace. ... Healthcare, which provides specialty products and solutions to ...
Breaking Medicine News(10 mins):Health News:Cortec Closes Equity Transaction with 101 Mobility 2Health News:Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases 2Health News:Dr. Greg DeLange of the Estetica Institute Recently Performed Eye Surgery on Both Members of Popular Morning Radio Team 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 3Health News:General Data Acquires Triangle Biomedical Sciences 2Health News:General Data Acquires Triangle Biomedical Sciences 3
... Minutes after Elizabeth Edwards was presented with NHPCO,s Person ... podium to look at her notes as a shout came ... brightened her face as the audience of 1,600 broke out ... optimism that was reinforced by Edwards, remarks.Edwards received NHPCO,s Person ...
... 7 Ziehm Imaging, a provider of mobile ... of software-driven systems for targeted, less-invasive medical treatments, ... marketing agreement for the integration of mobile 3D ... Imaging and BrainLAB jointly pioneered the development of ...
... in certain areas, researchers say , , THURSDAY, May 7 ... stimulation improved symptoms and, in some cases, launched a ... suffered for decades and who had failed multiple other ... had depression for 27 years and had failed about ...
... shows that Wild Blueberries may have a cardio-protective effect, ... vessels to oxidative stress. (Sources: Journal of Medicinal ... of Nutritional Biochemistry , 2009, Jan 19) The studies ... potential protective effect of Wild Blueberries in the diet ...
... May 7 Celebrity cook Paula Deen has ... the safety of pork since the H1N1 flu ... is speaking out.To view the Multimedia News Release, ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090507/NY13156 )"You know y,all, ...
... 7 Conseco, Inc. (NYSE: CNO ) ... that its subscribers who hold Conseco, Inc. stock vote ... for a dissident nominee for the ninth director up ... its recommendation to elect a dissident at Conseco,s upcoming ...
Cached Medicine News:Health News:Elizabeth Edwards Presented With Person of the Year Award by National Hospice and Palliative Care Organization at National Conference 2Health News:Ziehm Imaging and BrainLAB Extend Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS) to North America 2Health News:Ziehm Imaging and BrainLAB Extend Partnership for Intra-Operative 3D Imaging and Computer Assisted Surgery (CAS) to North America 3Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 2Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 3Health News:Brain Stimulation Therapy Eases Tough-to-Treat Depression 4Health News:New Research Demonstrates that Wild Blueberries May Support Cardiovascular Health 2Health News:New Research Demonstrates that Wild Blueberries May Support Cardiovascular Health 3Health News:Video: Paula Deen Calls on America to Reject Myths, Misinformation; Enjoy a Pork Chop Tonight 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: